Long-term survival in patients with coronary artery disease: importance of peripheral vascular disease. The Coronary Artery Surgery Study (CASS) Investigators
KA Eagle,
CS Rihal,
ED Foster,
MC Mickel,
and
BJ Gersh
Cardiac Unit, Massachusetts General Hospital, Boston 02114.
OBJECTIVES. The purpose of this study was to determine the importance of peripheral arterial disease in predicting long-term survival in patients with clinically evident coronary artery disease. BACKGROUND. Patients in the Coronary Artery Surgery Study (CASS) Registry were followed up for > 10 years. METHODS. Survival in 2,296 patients with peripheral arterial disease was compared with that of 13,953 patients without peripheral arterial disease using Kaplan-Meier survival curves. All patients had known stable coronary artery disease. Clinical, electrocardiographic (ECG), chest X-ray film and catheterization variables of the two groups were compared using the chi-square statistic or the two-sample t test. The independent effect of peripheral arterial disease (as well as other variables) on mortality was determined utilizing a Cox proportional hazards model. RESULTS. Patients with peripheral vascular disease were more likely to have hypertension, diabetes, family history of coronary artery disease, previous angina or myocardial infarction, previous coronary bypass surgery or to have smoked. They also had a higher incidence of congestive heart failure, ECG abnormality and modestly increased frequency of three-vessel disease. Independent correlates of long-term mortality for the entire cohort included age, smoking, diabetes, number of diseased coronary vessels, left ventricular function, hypertension, pulmonary disease, anginal class, previous myocardial infarction and peripheral vascular disease (all p < 0.001). At any point in time, patients with peripheral vascular disease had a 25% greater likelihood of mortality than patients without peripheral vascular disease (multivariate chi-square 25.83, hazard ratio 1.25, 95% confidence interval 1.15 to 1.36, p < 0.001). CONCLUSIONS. Peripheral vascular disease is a strong, independent predictor of long-term mortality in patients with stable coronary artery disease. Aggressive attempts at secondary disease prevention are warranted in this high risk group.
This article has been cited by other articles:

|
 |

|
 |
 
D. L. Bhatt, E. D. Peterson, R. A. Harrington, F.-S. Ou, C. P. Cannon, C. M. Gibson, N. S. Kleiman, R. G. Brindis, W. F. Peacock, S. J. Brener, et al.
Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes
Eur. Heart J.,
May 2, 2009;
30(10):
1195 - 1202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Criqui, J. K. Ninomiya, D. L. Wingard, M. Ji, and A. Fronek
Progression of Peripheral Arterial Disease Predicts Cardiovascular Disease Morbidity and Mortality
J. Am. Coll. Cardiol.,
November 18, 2008;
52(21):
1736 - 1742.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Chu, F. G. Bakaeen, X. L. Wang, T. K. Dao, S. A. LeMaire, J. S. Coselli, and J. Huh
The Impact of Peripheral Vascular Disease on Long-Term Survival After Coronary Artery Bypass Graft Surgery
Ann. Thorac. Surg.,
October 1, 2008;
86(4):
1175 - 1180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Haugen, I. P. Casserly, J. G. Regensteiner, and W. R. Hiatt
Risk assessment in the patient with established peripheral arterial disease
Vascular Medicine,
November 1, 2007;
12(4):
343 - 350.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mantha, J. Foss, J. E. Ellis, and M. F. Roizen
Intense Cardiac Troponin Surveillance for Long-Term Benefits Is Cost-Effective in Patients Undergoing Open Abdominal Aortic Surgery: A Decision Analysis Model
Anesth. Analg.,
November 1, 2007;
105(5):
1346 - 1356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Golomb, T. T. Dang, and M. H. Criqui
Peripheral Arterial Disease: Morbidity and Mortality Implications
Circulation,
August 15, 2006;
114(7):
688 - 699.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Hankey, P. E. Norman, and J. W. Eikelboom
Medical Treatment of Peripheral Arterial Disease
JAMA,
February 1, 2006;
295(5):
547 - 553.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Fuster, Z. A. Fayad, P. R. Moreno, M. Poon, R. Corti, and J. J. Badimon
Atherothrombosis and High-Risk Plaque: Part II: Approaches by Noninvasive Computed Tomographic/Magnetic Resonance Imaging
J. Am. Coll. Cardiol.,
October 4, 2005;
46(7):
1209 - 1218.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Aboyans, P. Lacroix, A. Postil, J. Guilloux, F. Rolle, E. Cornu, and M. Laskar
Subclinical Peripheral Arterial Disease and Incompressible Ankle Arteries Are Both Long-Term Prognostic Factors in Patients Undergoing Coronary Artery Bypass Grafting
J. Am. Coll. Cardiol.,
September 6, 2005;
46(5):
815 - 820.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. O'Rourke, H. B. Quinton, W. Piper, F. Hernandez, J. Morton, B. Hettleman, M. Hearne, W. Nugent, G. T. O'Connor, and D. J. Malenka
Survival in patients with peripheral vascular disease after percutaneous coronary intervention and coronary artery bypass graft surgery
Ann. Thorac. Surg.,
August 1, 2004;
78(2):
466 - 470.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Karthik, G. Musleh, A. D. Grayson, D. J. M. Keenan, D. M. Pullan, W. C. Dihmis, R. Hasan, and B. M. Fabri
Coronary surgery in patients with peripheral vascular disease: effect of avoiding cardiopulmonary bypass
Ann. Thorac. Surg.,
April 1, 2004;
77(4):
1245 - 1249.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Narins, W. Zareba, A. J. Moss, V. J. Marder, P. M. Ridker, R. J. Krone, and E. Lichstein
Relationship Between Intermittent Claudication, Inflammation, Thrombosis, and Recurrent Cardiac Events Among Survivors of Myocardial Infarction
Arch Intern Med,
February 23, 2004;
164(4):
440 - 446.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. S. Aronow
Management of Peripheral Arterial Disease of the Lower Extremities in Elderly Patients
J. Gerontol. A Biol. Sci. Med. Sci.,
February 1, 2004;
59(2):
M172 - 177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Allison, M. H. Criqui, and C. M. Wright
Patterns and Risk Factors for Systemic Calcified Atherosclerosis
Arterioscler Thromb Vasc Biol,
February 1, 2004;
24(2):
331 - 336.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S Coccheri and G Palareti
The cardiovascular risk burden of intermittent claudication
Eur. Heart J. Suppl.,
March 1, 2002;
4(suppl_B):
B46 - B49.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Perrone-Filardi and M. Chiariello
Coronary artery disease and intermittent claudication: how to manage the patient
Eur. Heart J. Suppl.,
March 1, 2002;
4(suppl_B):
B58 - B62.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Feldman, B. Fusman, J. F. McKinsey, R. S. Litwack, D. M. Gilligan, V. DeGruttola, D. Poldermans, E. Boersma, I. R. Thomson, and T. H. Lee
Beta-Blockade for Patients Undergoing Vascular Surgery
N. Engl. J. Med.,
April 6, 2000;
342(14):
1051 - 1053.
[Full Text]
|
 |
|

|
 |

|
 |
 
K. A. Eagle, R. A. Guyton, R. Davidoff, G. A. Ewy, J. Fonger, T. J. Gardner, J. P. Gott, H. C. Herrmann, R. A. Marlow, W. C. Nugent, et al.
ACC/AHA guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/ American Heart Association task force on Practice Guidelines (Committee to revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery)
J. Am. Coll. Cardiol.,
October 1, 1999;
34(4):
1262 - 1347.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Burek, K. Sutton-Tyrrell, M. M. Brooks, B. Naydeck, N. Keller, M. A. Sellers, G. Roubin, R.u. Jandova, and C. S. Rihal
Prognostic importance of lower extremity arterial disease in patients undergoing coronary revascularization in the bypass angioplasty revascularization investigation (BARI)
J. Am. Coll. Cardiol.,
September 1, 1999;
34(3):
716 - 721.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Mannheimer, T. Eliasson, L.-E. Augustinsson, C. Blomstrand, H. Emanuelsson, S. Larsson, H. Norrsell, and A. Hjalmarsson
Electrical Stimulation Versus Coronary Artery Bypass Surgery in Severe Angina Pectoris : The ESBY Study
Circulation,
March 31, 1998;
97(12):
1157 - 1163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Wilt, H. B. Rubins, S. J. Robins, W. A. Riley, D. Collins, M. Elam, G. Rutan, and J. W. Anderson
Carotid Atherosclerosis in Men With Low Levels of HDL Cholesterol
Stroke,
October 1, 1997;
28(10):
1919 - 1925.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. J. Wilt, H. B. Rubins, D. Collins, T. Z. O'Connor, G. H. Rutan, S. J. Robins, and the Veterans Affairs High-Density Lipoprotein Inte
Correlates and Consequences of Diffuse Atherosclerosis in Men With Coronary Heart Disease
Arch Intern Med,
June 10, 1996;
156(11):
1181 - 1188.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Wilt, B. R. Davis, D. G. Meyers, J.-L. Rouleau, and F. M. Sacks
Prevalence and Correlates of Symptomatic Peripheral Atherosclerosis in Individuals with Coronary Heart Disease and Cholesterol Levels Less Than 240 mg/dL: Baseline Results from the Cholesterol And Recurrent Events (CARE) Study
Angiology,
June 1, 1996;
47(6):
533 - 541.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. S. Douglas and G. S. Ginsburg
The Evaluation of Chest Pain in Women
N. Engl. J. Med.,
May 16, 1996;
334(20):
1311 - 1315.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Birkmeyer, H. B. Quinton, N. J. O'Connor, M. D. McDaniel, B. J. Leavitt, D. C. Charlesworth, F. Hernandez, M. A. Ricci, and G. T. O'Connor
The Effect of Peripheral Vascular Disease on Long-term Mortality After Coronary Artery Bypass Surgery
Arch Surg,
March 1, 1996;
131(3):
316 - 321.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Mason, D. K. Owens, R. A. Harris, J. P. Cooke, and M. A. Hlatky
The Role of Coronary Angiography and Coronary Revascularization Before Noncardiac Vascular Surgery
JAMA,
June 28, 1995;
273(24):
1919 - 1925.
[Abstract]
[PDF]
|
 |
|
|